Search

Grifols SA

Uždarymo kaina

SektoriusFinansų sektorius

10.015 1.45

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

9.868

Max

10.065

Pagrindiniai rodikliai

By Trading Economics

Pajamos

213M

286M

Pardavimai

174M

1.9B

P/E

Sektoriaus vid.

14.782

22.368

Pelnas, tenkantis vienai akcijai

0.226

Pelno marža

15.261

Darbuotojai

25,258

EBITDA

182M

535M

Dividendai

By Acuity

Kitas uždarbis

2026-11-03

Kitas dividendų mokėjimo data

2026-09-02

Kita Ex Dividend data

2026-08-31

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

9.5M

6.6B

Ankstesnė atidarymo kaina

8.57

Ankstesnė uždarymo kaina

10.015

Naujienos nuotaikos

By Acuity

50%

50%

150 / 436 reitingas Finance

Grifols SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-24 23:46; UTC

News

PG&E Corp shares are lower in after-market hours despite announcing an expansion of its Vehicle to Everything program and analysts' fair value estimate of $22.59.

2026-08-24 23:46; UTC

News

DA Davidson initiated coverage of Vulcan Materials Co with a Buy rating. Shares traded higher in after-market hours following Monday's close of $276.04.

2026-08-24 23:46; UTC

News

Jack Henry & Associates appoints Richard N. Preece to its Board of Directors, effective August 20, 2026. Shares are higher in after-market trading.

2026-08-24 23:46; UTC

News

Parker-Hannifin Corp filed a mixed securities shelf to raise capital. Shares advanced in after-market trading, continuing a trend of higher daily closes.

2026-08-24 23:31; UTC

News
Social Media

Kura Oncology shares are higher in after-market hours following CEO Troy Wilson's $1.2 million stock purchase, boosting his ownership to 1.214 million shares.

2026-08-24 23:26; UTC

News

National Beverage Corp's shares are lower in after-market hours, despite recent strength and five consecutive higher closes, amid geopolitical concerns affecting market sentiment.

2026-08-24 23:21; UTC

News

USD/HKD is trading lower, impacted by a stronger U.S. Dollar and economic pressures from new sanctions on Iran. Limited fluctuations persist in the market.

2026-08-24 23:16; UTC

News

Trade Desk Inc's stock fell in after-hours trading following a prospectus filing for a mixed shelf offering of various securities. The company holds $1.12 billion in cash.

2026-08-24 23:16; UTC

News

Coinbase Global Inc shares declined in after-market trading following the company's integration of Chainlink for real-time pricing of tokenized stocks on Base.

2026-08-24 23:16; UTC

News

Diamondback Energy shares are lower in after-market hours amid concerns from CEO Van't Hof's recent insider selling of 10,000 shares at $214.66 each.

2026-08-24 23:11; UTC

News

Nasdaq Inc shares are trading lower in after-market hours, reflecting broader market declines driven by weakness in technology stocks and geopolitical tensions.

2026-08-24 23:11; UTC

News

Copart Inc shares are lower in after-market hours, reflecting unusual volatility amid broader market concerns over geopolitical tensions and economic disruptions.

2026-08-24 23:06; UTC

Event
News

Gilead Sciences gains after European approval for Trodelvy and raises 2026 sales guidance to $30.1–$30.4 billion, reflecting strong performance in HIV and oncology.

2026-08-24 23:01; UTC

Social Media
News

Re/Max Holdings Inc. announced a $450 million share repurchase authorization, contributing to a higher trading performance during after-market hours.

2026-08-24 23:01; UTC

News

Grand Canyon Education shares declined in after-market hours following CFO Daniel E. Bachus's placement on paid administrative leave amid an ongoing investigation.

2026-08-24 23:01; UTC

News

Herc Holdings shares rise in after-market trading following director Erik Olsson's $503K purchase of 3.1K shares, signaling potential confidence in the company.

2026-08-24 23:01; UTC

News

Tyson Foods announced a $1 million commitment to the Harvest to Hallways initiative, enhancing childhood nutrition and food access, contributing to positive sentiment.

2026-08-24 23:01; UTC

News

Oshkosh shares are higher in after-market trading following praise from Secretary of War Pete Hegseth for the company's defense manufacturing capabilities and tactical vehicles.

2026-08-24 23:01; UTC

News

Vistra Corp shares rose in after-market trading after CEO James Burke bought 2,000 shares for $270,000, increasing his total ownership to 1.235 million shares.

2026-08-24 22:51; UTC

News
Social Media

Boeing Co received a $131.23 billion contract for the F-15 Eagle Crest, with shares trading higher in after-market hours following the announcement.

2026-08-24 22:16; UTC

News

A federal court upheld an $83.4 million award against Guardant Health for patent infringement, though shares are trading higher in after-market hours.

2026-08-24 22:16; UTC

News

Kenneth S. Courtis bought $3.2 million in Alpha Metallurgical Resources shares, contributing to modest after-market gains following recent insider purchases.

2026-08-24 22:06; UTC

News

Peabody Energy shares are lower in after-market hours following a class action lawsuit alleging misleading statements about its Centurion mine operations.

2026-08-24 22:01; UTC

News

Savara Inc. will present Phase 3 trial results for molgramostim at the European Respiratory Society Congress in 2026. Shares are higher in after-market trading.

2026-08-24 21:41; UTC

News

Franklin Resources announces cash distributions for ETFs, with payments set for September 2026. Shares are trading higher in after-market hours following the news.

2026-08-24 21:02; UTC

News

DA Davidson initiated coverage of Advanced Drainage Systems with a Buy rating. Shares rose in after-market trading, closing at $143.73.

2026-08-24 21:01; UTC

News

Owens Corning shares rise in after-market trading following a Buy rating from DA Davidson analyst Garik Shmois. The stock closed at $148.06.

2026-08-24 20:07; UTC

Social Media
News

Uber Technologies has partnered with Zoomcar to offer intercity ride options in India. Shares are higher as the initiative launches in major cities.

2026-08-24 20:07; UTC

News
Correlated Moves
Social Media

NVIDIA Corp's stock is lower amid negative sentiment from a senior manager's indictment for alleged AI chip smuggling and rising costs for customers.

2026-08-24 20:07; UTC

News

Impinj Inc shares are lower amid pressure in the Semiconductors sector and concerns over licensing revenue from NXP. Adjusted EBITDA margin is 15%.

Akcijų palyginimas

Kainos pokytis

Grifols SA Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

150 / 436 reitingas Finansų sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Grifols SA

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factorVIII/von Willerbrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It markets diagnostic testing equipment, reagents, and other equipment; biological products; manufactures and sells plasma to third parties; and involves in research activities, as well as markets pharmaceutical products for hospital pharmacies. In addition, the company offers Yimmugo PID, an immunology drug; and Yimmugo ITP, a hematology drug. Further, it develops Xembify Pre-filled syringes, FlexBag, and Prolastin vials; Xembify Biweekly dosing, Prolastin-C, Fostamatinib2, and VISTASEAL which are in Phase IV development stage; Xembify, Albumin 20% and 5%, Fibrinogen, Trimodulin, Cytotec pregnancy, and AMBAR-Next in Phase III development stage; and AKST4290 that is in Phase II clinical development. Additionally, it offers recIG, Alpha-1 AT in non-cystic fibrosis bronchiectasis, ATIII, GIGA 2339, GIGA564, and OSIG. It has collaboration agreements with Canadian Blood Services for the processing of other plasma-derived products and with GIANT; and GigaGen to develop recombinant polyclonal immunoglobulin therapies. The company was founded in 1909 and is headquartered in Barcelona, Spain.
help-icon Live chat